- Home
- VERV vs NRIM Comparison
VERV vs NRIM Comparison
Compare VERV & NRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERV
- NRIM
- Stock Information
- Founded
- VERV 2018
- NRIM 1990
- Country
- VERV United States
- NRIM United States
- Employees
- VERV N/A
- NRIM N/A
- Industry
- VERV Medicinal Chemicals and Botanical Products
- NRIM Savings Institutions
- Sector
- VERV Health Care
- NRIM Finance
- Exchange
- VERV Nasdaq
- NRIM Nasdaq
- Market Cap
- VERV 1.0B
- NRIM 514.9M
- IPO Year
- VERV 2021
- NRIM N/A
- Fundamental
- Price
- VERV $11.06
- NRIM $94.71
- Analyst Decision
- VERV Buy
- NRIM
- Analyst Count
- VERV 11
- NRIM 0
- Target Price
- VERV $14.57
- NRIM N/A
- AVG Volume (30 Days)
- VERV 7.6M
- NRIM 72.9K
- Earning Date
- VERV 08-07-2025
- NRIM 07-23-2025
- Dividend Yield
- VERV N/A
- NRIM 2.65%
- EPS Growth
- VERV N/A
- NRIM 46.48
- EPS
- VERV N/A
- NRIM 7.52
- Revenue
- VERV $59,613,000.00
- NRIM $164,695,000.00
- Revenue This Year
- VERV $47.32
- NRIM N/A
- Revenue Next Year
- VERV N/A
- NRIM $7.05
- P/E Ratio
- VERV N/A
- NRIM $12.85
- Revenue Growth
- VERV 271.44
- NRIM 26.35
- 52 Week Low
- VERV $2.87
- NRIM $57.00
- 52 Week High
- VERV $11.41
- NRIM $100.21
- Technical
- Relative Strength Index (RSI)
- VERV 78.23
- NRIM 56.53
- Support Level
- VERV $11.16
- NRIM $96.01
- Resistance Level
- VERV $11.30
- NRIM $100.21
- Average True Range (ATR)
- VERV 0.12
- NRIM 2.39
- MACD
- VERV -0.18
- NRIM 0.07
- Stochastic Oscillator
- VERV 12.50
- NRIM 61.16
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations.
About NRIM Northrim BanCorp Inc
Northrim BanCorp Inc is a bank holding company. The Company operates in three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. It generates maximum revenue from the Community Banking segment which offers loan and deposit products to business and consumer customers in its market areas and operates nearly 20 branches throughout Alaska.